– Overcoming challenges when moving from non-clinical to clinical
When: May 27th
Time: 10:00 to 11:30 CET
Place: Digital webinar
Register here
Going from non-clinical to clinical is no easy step. Join our free webinar on May 27th and listen to a few of our key experts from essential product development areas to talk about how to survive and minimize the early risks biotech companies face during the life-cycle of product development. We have a complete panel of experienced experts who will go through key elements to consider in the clinical development process.
This event is designed to help biotech companies in early development however, the content will also be helpful for the full life cycle of a product. View the agenda below to learn more.
* Please kindly note that this event is not for competitor service providers.
Agenda:
| 9:45 | The Meeting opens up for early login | |
| 10:00 | Introduction of team | |
| 10:05 | Factors to consider when selecting a manufacturer. The value of a GMP audit |
Hilde Ringstad, Director Quality Assurance and Compliance
|
| 10:15 | CMC/IMPD Crucial CMC regulatory compliance strategy In early biotech |
Lone Dyrby, Regulatory Director – Denmark |
| 10:25 |
Pipeline strategy; Clinical trials and their relative value inflection points
|
Austin Smith, VP Clinical Development, Oncology specialist |
| 10:35 |
The value of Scientific advice
|
Marie Moores, EVP Clinical Operations |
| 10:45 | Biostatisticians early in the design |
Christina Ehrenkrona
|
| 10:55 | The importance of proper data handling |
Mario Baban, EDC Group Manger
|
| 11:05 | Clinical Trial Safety |
Tina Elberling, Director Safety International Operations
|
| 11:15 |
Open Q/A
|
|
| 11:30 |
End
|
Read more about our speakers and event details here.
